News — New drug

DEA Targets New Drug, Kratom, Schedule 1 Substance like Heroin
Posted by UTS -

The U.S. Drug Enforcement Agency (DEA) has added another drug to its controlled-substance list. This drug, which is growing acclaim for its various uses, is also still relatively unknown to most of the general public. Kratom, or Ketum, is a plant species Mitragyna speciosa which is most related to the coffee plant. Kratom has been promoted on many websites as a “safe and harm free” herbal supplement to treat aches and pain.   What does the DEA think?   Well, on September 30, 2016, the DEA will include kratom on its Schedule 1 Controlled Substance List. This classification will put kratom...

View Article →

Neos Therapeutics: Dissolvable Amphetamine Drug for Kids
Posted by UTS -

img source: neos therapeutics   Recently, the CDC has raised concerns with over-medicating children with ADHD.   Enter Adzenys – a new medication in this ADHD market. This new dissolvable pill aimed directly at children for its ease-of-use and orange-flavoring is concerning doctors and parents due to the fact that the medication is a Schedule 2 Controlled Substance, and the drug’s main selling point of “ease-of-use” may facilitate abuse. With such a widespread use of stimulants being used in today’s society, many in the medical community insist that creating an ODT (orally disintegrating tablet) version of an ADHD drug is a...

View Article →

Eli Lilly Pharma Giant Reveals Plans to Release 20 New Drugs in 5 Years
Posted by UTS -

      Indianapolis-based pharmaceutical giant Eli Lilly lly laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an investor presentation in May. Eli said it hopes to add a significant number of uses for its existing therapies in order to bolster those drugs’ market strength. They will focus on key franchises such as diabetes, oncology, and neurodegenerative diseases, such as Alzheimer’s. In addition, they will add immunology to their core therapeutic spaces. The pharma giant also had to ditch one of its pipeline hopefuls, a cardiovascular treatment meant to boost -good- HDL cholesterol,...

View Article →

Salvia Plant: Dopamine Treatment
Posted by UTS -

 The ancient beliefs of the Mazatec people of Oaxaca, southern Mexico, have accumulated years of knowledge in herbal healing. They use rituals, incense, and chanting to cure illness and travel to spiritual or astral dimensions. Their use of Salvia, a plant in the mint family, has been found to alter dopamine levels in ancient parts of the brain responsible for motivation, reward, and the internal sense of what is going on in our bodies. In addition, the Mazatec have used Salvia to treat addiction for hundreds of years. Salvia can be used by ingesting fresh leaves or by drinking their...

View Article →

Aprecia's 3D Printed Drug, Approved by FDA
Posted by UTS -

Photo credit: aprecia.com Aprecia, the pharmaceutical company who has licensed rights to pharmaceutical applications for 3-D Printing (3DP), has developed a ground-breaking drug for the treatment of certain seizures in those suffering from epilepsy. The drug in question – called Spritam – is the first medication approved by the FDA utilizing this 3DP platform with the first batch of pills expected to hit the shelf by early next year. “By combining 3DP technology with a highly-prescribed epilepsy treatment, Spritam is designed to fill a need for patients who struggle with their current medication experience,” said Don Wetherhold, who is the CEO...

View Article →